Breast Cancer Trial, Recruiting NCT06235931 Sponsor: Second Affiliated Hospital of Soochow University Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT06235931
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 65 years old or older
  • You have been diagnosed with stage IV breast cancer that has been confirmed by a tissue biopsy, and your cancer is a specific type called "triple positive" (HER2-positive, estrogen receptor-positive, and progesterone receptor-positive, as defined by specific lab test results)
  • You have not had any prior treatment for this stage of cancer, OR if you previously had hormone therapy or anti-HER2 therapy after surgery, it was completed more than one year ago
  • Your general health and ability to carry out daily activities falls within an acceptable range as measured by a standard medical scale (ECOG score of 0–3) (confirm with trial site)
  • Your doctors expect you to live for at least 12 weeks
  • Your blood counts are at acceptable levels, including white blood cells, platelets, and hemoglobin
  • Your liver and kidney function tests are within acceptable ranges
  • Your heart is pumping blood effectively enough, as shown by a heart ultrasound (confirm with trial site)

Who may not be able to join:

  • Your breast cancer cannot be measured or tracked using standard tests
  • You have had another type of cancer in the last five years
  • You received certain targeted cancer treatments (including anti-HER2 therapy or T-DM1) less than one year ago
  • You have a history of bowel blockage, are unable to eat normally, or have ongoing digestive problems where diarrhea is a main symptom
  • You have a mental health condition or substance use issue that would make it difficult to participate in the trial
  • You are currently pregnant or breastfeeding
  • The trial doctors have other reasons they feel you would not be suitable for the trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13913501391

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Second Affiliated Hospital of Soochow University
Registry
ClinicalTrials.gov
Start date
1 February 2024
Est. completion
1 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Progression Free Survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov